Reduction in blood pressure with a sodium-reduced, potassium- and magnesium-enriched mineral salt in subjects with mild essential hypertension

Hypertension Research - Clinical and Experimental

Volumn 21, Issue 4, 1998, Pages 235-243

  Kawasaki, Terukazu ^a   Itoh, Kazue ^b   Kawasaki, Masumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NAKAMURA GAKUEN UNIVERSITY   (Japan)

Author keywords

Blood pressure; Dietary sodium; Hypertension; Magnesium supplement; Mineral salt; Potassium supplement

Indexed keywords

CHLORIDE ION; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM; MINERAL; POTASSIUM; POTASSIUM ION; SODIUM; SODIUM CHLORIDE; SODIUM ION;

ADULT; AGED; ARTICLE; BLOOD CHEMISTRY; BLOOD PRESSURE; CHLORIDE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIETARY INTAKE; ELECTROLYTE URINE LEVEL; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; JAPAN; MAGNESIUM URINE LEVEL; MALE; POTASSIUM BLOOD LEVEL; POTASSIUM URINE LEVEL; RANDOMIZED CONTROLLED TRIAL; SALT INTAKE; SODIUM BLOOD LEVEL; SODIUM RESTRICTION; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE;

EID: 0032432986     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.21.235     Document Type: Article

References (43)

1. Kempner W: Treatment of hypertensive vascular disease with rice diet. Am J Med 1948; 4: 545-577.
2. Kawasaki T, Delea CS, Bartter FC, Smith H: The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension. Am J Med 1978; 64: 193-198.
3. Kawasaki T, Ueno M, Uezono K, et al: Salt intake and hypertension. Jpn Circ J 1981; 45: 810-816.
4. MacGregor GA, Markandu ND, Best FE: Double-blind crossover trial of moderate sodium restriction in essential hypertension. Lancet 1982; i: 351-356.
5. Intersalt Cooperative Research Group: Intersalt: An international study of electrolyte excretion and blood pressure: results for 24 hour urinary sodium and potassium excretion. Br Med J 1988; 297: 319-328.
6. Elliott P: Observational studies salt and blood pressure. Hypertension 1991; 17 (Suppl 1): 3-8.
7. Law MR, Frost CD, Wald NJ: By how much does dietary salt restriction lower blood pressure?: analysis of data trial of salt reduction. Br Med J 1991; 302: 819-824.
8. Cutler JA, Follmann D, Elliott P, Suh IL: An overview of randomized trials of sodium reduction and blood pressure. Hypertension 1991; 17 (Suppl I): I-27-I-33.
9. Dyer AR, Shipley M, Elliott P, for the INTERSALT Cooperative Research Group: Urinary electrolyte excretion in 24 hours and blood pressure in the INTERSALT study: I. Estimates of reliability. Am J Epidemiol 1994; 139: 927-939.
10. Rikimaru T, Fujita Y, Okuda T, et al: Responses of sodium balance, blood pressure, and other variables to sodium loading in Papua New Guinea highlanders. Am J Clin Nutr 1988; 47: 502-508.
11. Kawasaki T, Itoh K, Uezono K, et al: Investigation of high salt intake in a Nepalese population with low blood pressure. J Hum Hypertens 1993; 7: 131-140.
12. Whelton PK, He J, Cutler JA, et al: Effects of oral potassium on blood pressure: meta-analysis of randomized controlled trials. JAMA 1997; 277: 1624-1632.
13. Yamori Y, Kihara M, Nara Y, et al: Hypertension and diet: multiple regression analysis in a Japanese farming community. Lancet 1981; i: 1204.
14. Kihara M, Fujikawa J, Ohtaka M, et al: Interrelationships between blood pressure, sodium, potassium, serum cholesterol and protein intake in Japanese. Hypertension 1984; 6: 736-742.
15. Lai S, Yuanchang T, Weiling H, et al: Urinary electrolytes and blood pressure in three Yi farmer populations, China. Hypertension 1989; 13: 22-30.
16. Motoyama T, Sano H, Fukuzaki H: Oral magnesium supplementation in patients with essential hypertension. Hypertension 1989; 13: 227-232.
17. Witteman JCM, Grobbee DE, Derkx FHM, et al: Reduction of blood pressure with oral magnesium supplementation in women with mild to moderate hypertension. Am J Clin Nutr 1994; 60: 129-135.
18. Geleijnse JM, Witteman JCM, Bak AAA, et al: Reduction in blood pressure with a low sodium, high potassium, high magnesium salt in older subjects with mild to moderate hypertension. Br Med J 1994; 309: 436-440.
19. Itoh K, Kawasaki T, Yoshida H, Nakamura M: Effects of oral magnesium supplementation on blood pressure, serum lipids and urinary catecholamine in healthy young subjects. J Hypertens 1994; 12 (Suppl 3): s86 (Abstract).
20. Itoh K, Kawasaki T, Nakamura M: The effects of oral magnesium supplementation on blood pressure, serum lipids and related variables in apparently healthy Japanese subjects. Br J Nutr 1997; 78: 737-750.
21. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: The sixth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC-VI). Arch Intern Med 1997; 157: 2413-2446.
22. Guidelines Sub-committee: 1993 Guidelines for the management of mild hypertension: Memorandum from a World Health Organization/International Society of Hypertension. J Hypertens 1993; 11: 905-918.
23. Weinberger MH, Fineberg NS: Sodium and volume sensitivity of blood pressure: age and pressure change over time. Hypertension 1991; 18: 67-71.
24. Karppanen H, Tanskanen A, Tuomilehto J, et al: Safety and effects of potassium- and magnesium-containing low sodium salt mixtures. J Cardiovasc Pharmacol 1984; 6: S236-S243.
25. Mervaala EMA, Himberg JJ, Laakso J, Tuomainen P, Karppanen H: Beneficial effects of a potassium-and magnesium-enriched salt alternative. Hypertension 1992; 19: 535-540.
26. Goh R, Saito T, Arase T, Higuchi S: A comparison of intra-arterial, oscillometric and auscultatory measurements of blood pressure: influence of blood pressure level and arteriosclerosis. Masui 1988; 37: 189-196 (Japanese with English Abstract).
27. Kawasaki T, Itoh K, Uezono K, Sasaki H: A simple method for estimating 24 h urinary sodium and potassium excretion from second morning voiding urine specimen in adults. Clin Exp Pharmacol Physiol 1993; 20: 7-14.
28. Friedewald WT, Levy RI, Fredrickson DS: Estimation of concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499.
29. Itoh K, Kawasaki T: Clinical and nutritional study of low sodium, high potassium and high magnesium salt on sensory test and electrolyte balance. Jpn J Nutr 1997; 55: 263-272 (Japanese with English Abstract).
30. Gilleran G, O'leary M, Bartlett WA, et al: Effects of dietary sodium substitution with potassium and magnesium in hypertensive Type II diabetics: a randomized blind controlled parallel study. J Hum Hypertens 1996; 10: 517-521.
31. De la Sierra A, Del mar Lluch M, Coca A, et al: Fluid, ionic and hormonal changes induced by high salt intake in salt-sensitive and salt-resistant hypertensive patients. Clin Sci 1996; 91: 155-161.
32. Altura BM, Altura BT: Role of magnesium in the pathogenesis of hypertension: relationship to its action on cardiac, vascular smooth muscle, and endothelial cells updated. in Laragh JH, Brenner BM (eds): Hypertension: Pathophysiology, Diagnosis, and Management, Vol I, 2nd ed, New York, Raven Press, 1995, pp1213-1242.
33. MacGregor GA, Markandu ND, Best FE, et al: Double-blind randomised crossover trial of moderate sodium restriction in essential hypertension. Lancet 1982; i: 351-355.
34. Stamler R, Stamler J, Gosch FC, et al: Primary prevention of hypertension by nutritional-hygienic means: final report of a randomized, controlled trial. JAMA 1989; 262: 1801-1807.
35. The Trials of Hypertension Prevention Collaborative Research Group: The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the trials of hypertension prevention, Phase I. JAMA 1992; 267: 1213-1220.
36. Cappuccio FP, MarKandu ND, Carney C, Sagnella GA, MacGregor GA: Double-blind randomised trial of modest salt restriction in older people. Lancet 1997; ii: 850-854.
37. Graudal NA, Galloe AM, Garred P: Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride: a meta-analysis. JAMA 1998; 279: 1383-1391.
38. Davis WH, Leary WP, Reyes AJ, Olhaberry JV: Mono-therapy with magnesium increases abnormally low high density lipoprotein cholesterol: a clinical assay. Curr Ther Res Clin Exp 1984; 36: 341-346.
39. Parkin SM, Walker K, Ashby P, Robinson DS: Effects of glucose and insulin on the activation of lipoprotin lipase and on protein-synthesis in rat adipose tissue. Biochem J 1980; 188: 193-199.
40. Itoh K, Kawasaki T, Uezono K, Sasaki H: Effects of high potassium diet on blood pressure and lipid metabolism in mild hypertensive subjects. Jpn J Hypertens 1988; A11: 737 (Abstract).
41. Rasmussen HS, Aurup P, Goransson L, et al: Magnesium deficiency in patients with ischemic heart disease, with and without acute myocardial infarction, uncovered by an intravenous loading test. Arch Intern Med 1988; 148: 329-332.
42. Rasmussen HS, Aurup P, Goldstein K, et al: Influence of magnesium substitution therapy on blood lipid composition in patients with ischemic heart disease. Arch Intern Med 1989; 149: 1050-1053.
43. MacGregor GA, Sever PS, conveners of CASH (Consensus Action on Salt and Hypertension): Salt-overwhelming evidence but still no action: can a consensus be reached with the food industry? Br Med J 1996; 312: 1287-1289.